NASDAQ: AMRNAmarin Corp PLC Stock Ownership - Who owns Amarin?
Insider buying vs selling
Have Amarin Corp PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Steven B. Ketchum | EVP Chief Scientific Officer | 2026-01-02 | 2,041 | $13.96 | $28.49kSell |
| David Paul Keenan | EVP Chief Operating Officer | 2026-01-02 | 1,926 | $13.96 | $26.89kSell |
| Peter L. Fishman | SVP CFO | 2026-01-02 | 1,356 | $13.96 | $18.93kSell |
| Jonathan Provoost | EVP Chief Legal Officer | 2026-01-02 | 1,488 | $13.96 | $20.77kSell |
| Peter L. Fishman | SVP CFO | 2025-08-01 | 160 | $14.52 | $2.32kSell |
| Aaron Berg | President and CEO | 2025-06-26 | 38,363 | $15.90 | $609.97kSell |
| Diane E. Sullivan | Director | 2025-04-18 | 437 | $9.11 | $3.98kSell |
| Patrice Eadon Bonfiglio | Director | 2025-04-18 | 437 | $9.11 | $3.98kSell |
| Paul Cohen | Director | 2025-04-18 | 437 | $9.11 | $3.98kSell |
| Mark Dipaolo | Director | 2025-04-18 | 437 | $9.11 | $3.98kSell |
AMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AMRN insiders and whales buy or sell their stock.
AMRN Shareholders
What type of owners hold Amarin Corp PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James Healy | 4.55% | 18,924,976 | $279.71M | Insider |
| Abingworth LLP | 4.47% | 18,599,168 | $274.90M | Insider |
| Sofinnova Venture Partners VII L P | 2.05% | 8,513,388 | $125.83M | Insider |
| Southpoint Capital Advisors LP | 1.98% | 8,216,329 | $121.44M | Insider |
| Michael Torok | 1.17% | 4,850,000 | $71.68M | Insider |
| John F. Thero | 0.78% | 3,252,752 | $48.08M | Insider |
| Fountain Healthcare Partners Ltd | 0.61% | 2,534,782 | $37.46M | Insider |
| Sarissa Capital Management LP | 0.30% | 1,242,527 | $18.36M | Institution |
| Kynam Capital Management LP | 0.14% | 576,111 | $8.51M | Institution |
| Acadian Asset Management LLC | 0.11% | 456,580 | $6.75M | Institution |
AMRN vs General Drug Manufacturer Stocks
Amarin Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.